Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Ivabradine in heart failure: what about digoxin?

Gorman S, Boos C.

Lancet. 2008 Dec 20;372(9656):2113; author reply 2113-4. doi: 10.1016/S0140-6736(08)61923-6. No abstract available.

PMID:
19101387
2.

Digoxin in patients with heart failure.

Böhm M.

N Engl J Med. 1997 Jul 10;337(2):129-30; author reply 130-1. No abstract available.

PMID:
9221339
3.

Ivabradine in heart failure: hope or hype?

Deedwania PC.

Am J Cardiovasc Drugs. 2012 Dec 1;12(6):357-9. doi: 10.2165/11642100-000000000-00000. No abstract available.

PMID:
23181943
4.

Heart rate reduction in heart failure: ivabradine or beta blockers?

Guglin M.

Heart Fail Rev. 2013 Jul;18(4):517-28. doi: 10.1007/s10741-012-9347-6. Review.

PMID:
22972475
5.

A new indication for digoxin: to enable introduction and dose-escalation of ß-blocker therapy in severe heart failure.

Tan DK, Schlosshan D.

Int J Cardiol. 2012 Jun 28;158(1):154-5. doi: 10.1016/j.ijcard.2012.04.074. Epub 2012 May 4. No abstract available.

PMID:
22560914
6.

Treatment guidelines for heart failure stress multidrug approach.

Morey SS.

Am Fam Physician. 1999 Jun;59(11):3265-6. No abstract available.

7.

[Heart failure - up to date].

Müller-Edenborn B, Eriksson U.

Praxis (Bern 1994). 2013 Aug 21;102(17):1053-60. doi: 10.1024/1661-8157/a001381. Review. German.

PMID:
23965718
8.

A four-part regimen for clinical heart failure.

Freudenberger RS, Gottlieb SS, Robinson SW, Fisher ML.

Hosp Pract (1995). 1999 Sep 1;34(9):51-6, 59-64. Review.

PMID:
10901760
9.

Digoxin for the treatment of heart failure.

Hudson M, Pilote L.

N Engl J Med. 2003 Feb 13;348(7):661-3; author reply 661-3. No abstract available.

PMID:
12587574
10.

Current medical therapy for advanced heart failure.

Gheorghiade M, Cody RJ, Francis GS, McKenna WJ, Young JB, Bonow RO.

Heart Lung. 2000 Jan-Feb;29(1):16-32. Review. No abstract available.

PMID:
10636954
11.

Digoxin therapy: A persisting interest despite contrary winds.

Juillière Y, Selton-Suty C.

Arch Cardiovasc Dis. 2010 May;103(5):281-4. doi: 10.1016/j.acvd.2010.04.001.

12.

Limited role for ivabradine in the treatment of chronic heart failure.

Cullington D, Goode KM, Cleland JG, Clark AL.

Heart. 2011 Dec;97(23):1961-6. doi: 10.1136/heartjnl-2011-300041. Epub 2011 Sep 13.

PMID:
21917660
13.

[Treatment of cardiac failure].

Conthe Gutiérrez P, Pacho Jiménez E.

Rev Clin Esp. 2000 Oct;200(10):551-62. Review. Spanish. No abstract available.

PMID:
11153239
14.

The treatment of congestive heart failure with diuretics and nondiuretic agents.

Zatuchni J.

Clin Ther. 1988;10(4):328-49. Review. No abstract available.

PMID:
2908546
15.

Effect of ivabradine on early readmissions after hospitalization for worsening heart failure.

Borer JS, Böhm M, Ford I, Komajda M, Swedberg K, Tavazzi L.

JACC Heart Fail. 2015 Mar;3(3):268-9. doi: 10.1016/j.jchf.2014.12.004. No abstract available.

PMID:
25742766
16.

Reply: effect of ivabradine on early readmissions after hospitalization for worsening heart failure.

Gheorghiade M, Vaduganathan M, Fonarow GC.

JACC Heart Fail. 2015 Mar;3(3):269-70. doi: 10.1016/j.jchf.2014.12.010. No abstract available.

PMID:
25742767
18.

Heart failure.

McKelvie R.

Clin Evid. 2004 Dec;(12):115-43. Review. No abstract available. Update in: Clin Evid. 2006 Jun;(15):118-39.

PMID:
15865633
19.
20.

Sudden death in heart failure patients: effects of optimized medical therapy.

Kao W, Costanzo MR.

J Heart Lung Transplant. 2000 Aug;19(8 Suppl):S32-7. Review.

PMID:
11016485

Supplemental Content

Support Center